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Brainstem Auditory Evoked Responses in an Equine Patient
Population: Part I – Adult Horses
M. Aleman, T.A. Holliday†, J.E. Nieto, and D.C. Williams
Background: Brainstem auditory evoked response has been an underused diagnostic modality in horses as evidenced by
few reports on the subject.
Hypothesis/Objectives: To describe BAER findings, common clinical signs, and causes of hearing loss in adult horses.
Animals: Study group, 76 horses; control group, 8 horses.
Methods: Retrospective. BAER records from the Clinical Neurophysiology Laboratory were reviewed from the years
of 1982 to 2013. Peak latencies, amplitudes, and interpeak intervals were measured when visible. Horses were grouped
under disease categories. Descriptive statistics and a posthoc Bonferroni test were performed.
Results: Fifty-seven of 76 horses had BAER deficits. There was no breed or sex predisposition, with the exception of
American Paint horses diagnosed with congenital sensorineural deafness. Eighty-six percent (n = 49/57) of the horses were
younger than 16 years of age. The most common causes of BAER abnormalities were temporohyoid osteoarthropathy
(THO, n = 20/20; abnormalities/total), congenital sensorineural deafness in Paint horses (17/17), multifocal brain disease
(13/16), and otitis media/interna (4/4). Auditory loss was bilateral and unilateral in 74% (n = 42/57) and 26% (n = 15/57)
of the horses, respectively. The most common causes of bilateral auditory loss were sensorineural deafness, THO, and mul-
tifocal brain disease whereas THO and otitis were the most common causes of unilateral deficits.
Conclusions and Clinical Importance: Auditory deficits should be investigated in horses with altered behavior, THO,
multifocal brain disease, otitis, and in horses with certain coat and eye color patterns. BAER testing is an objective and
noninvasive diagnostic modality to assess auditory function in horses.
Key words: Deafness; Electrophysiology; Equine; Hearing.
Brainstem auditory evoked response (BAER) testingevaluates the integrity of the auditory pathway.1
The normal BAER consists of a sequence of 5–7
peaks, named as I to VII which occur during the first
10 milliseconds after the onset of a stimulus.1,2 Each
peak is thought to represent the depolarization of spe-
cific nuclei along this pathway.1 Reference values for
horses, ponies, and neonatal foals have been
reported.3–7 It is important to note the technique (ver-
tex to mastoid versus vertex to C2 vertebra) and
equipment (head phones versus insert ear phones [ie,
some models have a length of tubing between the
sound source and site of delivery which increases peak
latencies]) used for the recording of BAER for the
comparison of results with those of reference val-
ues.2,7,8 Further considerations include whether BAER
testing is performed under sedation or general anesthe-
sia.3–5 Abnormalities in the BAER are consistent with
hearing loss (deafness), which could be complete or
partial and acquired or congenital.1,9 Failure of con-
duction of sound waves from the ear canal to the inner
ear is termed conductive deafness whereas alterations
of the neural structures of the auditory pathway result
in sensorineural deafness.9
Despite the ease and noninvasiveness of the proce-
dure, the use of BAER as a diagnostic modality in
horses has been limited to a few reports which include
congenital sensorineural deafness of American Paint
horses, THO, presumed gentamicin toxicity, head
trauma, and brain lesions.6,7,10–20 Furthermore, there is
a lack of large scale studies to gain information about
hearing loss in horses and determine factors such as
breed predisposition, associated clinical signs, and the
occurrence of complete versus partial and bilateral ver-
sus unilateral hearing loss. The purpose of this study
was to review and report BAER results, signalment,
clinical signs, causes of hearing loss, and outcome.
This study included horses ≥1-year old. Foals were not
included because diseases of foals (especially neonatal
foals) may differ from those of adult horses.
Materials and Methods
Animals
This retrospective study included all horses of any breed and
≥1 year of age that had a BAER evaluation performed in the
Clinical Neurophysiology Laboratory at the William R. Pritchard
Veterinary Medical Teaching Hospital of the University of
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California at Davis between 1982 and 2013. The BAER database
included paper (1982–1998) and electronic (1999–2013) records.
Data collected consisted of signalment, presenting complaint,
physical and neurologic examination findings, BAER results, clini-
cal or definitive diagnosis, and outcome. BAER data (mean and
standard deviation of peak latencies) from 8 healthy adult horses
(5–20-year old) of Quarter Horse, Thoroughbred, and Warmblood
breeds were used as controls.7 Horses under study were grouped
into disease categories for comparison of BAER data with that of
control horses.
Brainstem Auditory Evoked Response Testing
Brainstem auditory evoked response testing was done according
to laboratory protocols for equine BAER and as described else-
where.7 Briefly, because of the duration of the study period, differ-
ent evoked potentials systemsa–e were used for recording BAER.
Horses were placed in examination stocks and sedated with xyla-
zine hydrochloride at a dosage of 0.3–0.4 mg/kg IV. For most
studies, insert earphonesf were placed deep into the external ear
canal (for early recordings, headphones were used). Subcutaneous
needle electrodesg were placed at the vertex (V), left mastoid (LM),
right mastoid (RM), and on the dorsal midline at the level of C2
vertebra (C2) for recording the BAER (Fig 1A). For some evoked
potential systems, an additional electrode was placed between the
occipital protuberance and C2 to serve as the ground (Z)7, whereas
with others, the contralateral mastoid served this purpose
(Fig 1A). Specifications for BAER recording and labeling of peaks
were the same as those described elsewhere.7 Each BAER record-
ing was the average of a minimum of 400 responses over a 10 mil-
liseconds epoch. An alternating (rarefaction plus condensation)
broadband click stimulus at 90 dB normal hearing level (nHL)
was applied individually to each ear. A simultaneous masking
sound was used on the contralateral side with an offset of 30 dB
nHL.7 All BAER studies were done in duplicate and 2 derivations
were recorded simultaneously: (1) vertex to ipsilateral mastoid (V-
M) and (2) vertex to C2 (V-C2).7
Determination of normal versus abnormal BAER was based
on the following measurements: Latency and amplitude for peaks
I, III, and V measured in milliseconds and microvolts (lV),
respectively; interpeak intervals (IPI) for latency among peaks
I–III, III–V, and I–V; and, amplitude ratio by dividing peak V
by peak I on the vertex to C2 derivation.7 The study was consid-
ered abnormal and categorized as follows: absence of identifiable
BAER peaks was consistent with complete hearing loss whereas
increased peak latency (prolonged beyond 2 standard deviations
[SD] from normal mean values),21 difficulty identifying peaks
(decreased amplitude) or both was suggestive of partial hearing
loss.7,21,22
Statistical Analysis
Descriptive statistics for age (mean, range) and BAER data
(mean, SD) were calculated. Horses were grouped under disease
categories for further comparison of data. To compare BAER
data from healthy horses to that of diseased horses, a one-way
ANOVA was performed; if statistical differences (P < .05) were
found, a posthoc Bonferroni test was done to determine statisti-
cal differences between groups.
Results
Animals
Seventy-six horses had BAER performed during the
study period. The horses were of Thoroughbred
(n = 22), Quarter Horse (n = 20), American Paint
(n = 15), Warmblood (n = 6), Arabian (n = 5), Appa-
loosa (n = 3), Tennessee Walker (n = 2), Morgan
(n = 1), Saddlebred (n = 1), and American Miniature
(n = 1) breeds. There were 35 mares, 28 geldings, and
13 intact males. Their ages ranged from 1 to 28 years
(mean, 8.5 years; median, 7 years). The most common
presenting complaint varied with disease and included
altered behavior, such as startling with environmental
stimuli (n = 22), leaning to 1 side (n = 22), head tilt
(n = 20), undefined gait deficits (n = 20), corneal ulcer-
ation (n = 15), and dysphagia (n = 15). Other com-
plaints included headshaking (n = 3), inability to stand
(n = 3), seizures (n = 2), and collapse (n = 2). The
complaint was not recorded in 15 horses. Suspected
hearing loss was reported in 12 horses (10 American
Paint and 2 paint Warmblood horses).
Physical and neurologic examination showed that
the most common clinical signs were those of sus-
pected hearing loss (n = 32; startling when
approached, not turning head or ears toward the
source of a loud noise), vestibular disease (n = 32;
head tilt, nystagmus, positional strabismus, leaning to
one side, ataxia), obtundation (n = 19), multiple cra-
nial nerve deficits (n = 16; mastication deficits with or
without masticatory muscle atrophy, facial paresis or
paralysis with or without vestibular signs, dysphagia,
tongue paresis), ataxia not associated with vestibular
disease (n = 12), and less common clinical signs such
as headshaking (n = 6), recumbency (n = 3), and stu-
por (n = 1). Diagnostic evaluation consisted of clinical
pathology testing (CBC, serum biochemistry, and cere-
brospinal fluid cytology and chemistry), otoscopic
examination, imaging of the head (radiographs, com-
puted tomography, or both), and in some cases screen-
ing for infectious pathogens and microbial culture of
tissues such as blood, fluid obtained from the tympanic
cavity, and cerebrospinal fluid.
Based on physical and neurologic examination
results (neuroanatomic localization) and diagnostic
evaluation, horses were grouped into one of the fol-
lowing categories: multifocal brain disorder with or
without spinal cord involvement, vestibular disease
(without other cranial nerves deficits and not associ-
ated with temporohyoid osteoarthropathy [THO]),
THO, sensorineural hearing loss (without other neu-
rologic deficits and no evidence of otitis), otitis (exter-
na, media, interna or some combination of these),
and other categories such as bilateral spontaneous ot-
oacoustic emissions (SOAEs) and neurologic deficits
not localized to the brain or cranial nerves (see
Table 1).
Of 16 horses with multifocal brain disease, 5 had
infectious encephalomyelitis with or without meningeal
involvement. Of these 5 horses, 2 were diagnosed with
equine protozoal myeloencephalopathy because of Sar-
cocystis neurona (presumptive diagnosis based on high
antibody titers on immunofluorescent antibody test), 1
with Halicephalobus gingivalis meningoencephalomyeli-
tis, 1 with Listeria monocytogenes, and 1 with mixed
bacterial meningoencephalomyelitis. Four of 16 horses
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Fig 1. (A) BAER electrode placement. Derivations used: vertex to mastoid (left, right) and vertex to C2. V, vertex; RM, right mastoid;
LM, left mastoid; C2, level of second cervical vertebra; and Z, ground. Ear phones not shown. (B) Normal BAER in healthy horse.7 BAER
peaks and troughs labeled (I, I’, II, III, IV, V, V’). Top 2 tracings = stimulation of left ear, bottom 2 tracings = stimulation of right ear; LM,
left mastoid; C2, level of second cervical vertebra, bar as indicated. (C) Horse with congenital sensorineural deafness. No BAER peaks in
either ear. Top 2 tracings = left ear (V-LM, V-C2), bottom 2 tracings = right ear (V-RM, V-C2). (D) Horse with multifocal brain disease.
Peak ratio V/I was less than 1.5 on the left ear, and there was no BAER on the right ear. Top 2 tracings = left ear (V-LM, V-C2), bottom 2
tracings = right ear (V-RM, V-C2). (E) Horse with multifocal brain disease. Bilateral BAER loss: difficult to identify peaks on the left ear
(therefore not marked) and none on the right ear. Top 2 tracings = left ear (V-LM, V-C2), bottom 2 tracings = right ear (V-RM, V-C2). (F).
BAER from a horse with THO. Top 2 tracings = left ear (V-LM, V-C2), bottom 2 tracings = right ear (V-RM, V-C2).
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had intracranial masses: 2 had melanoma in the
brainstem, 1 had a large glioblastoma multiforme in
the piriform lobe with severe compression of the brain,
and 1 had an abscess in the brainstem and otitis media
and interna. Three of 16 horses suffered from trau-
matic brain injury, had sustained skull fractures, and
had hematomas compressing the brainstem. In 4
horses, the cause of the multifocal brainstem deficits
was unknown. The outcome at discharge for all 76
horses is shown in Table 1.
Brainstem Auditory Evoked Response Testing
Based on BAER testing, 57 horses had hearing defi-
cits and 19 horses had BAER findings within reference
range (Fig 1B). Hearing deficits were bilateral in 42
and unilateral in 15 horses (Table 2). Complete bilat-
eral hearing loss was found in 19 horses of which 15
were American Paint horses (Fig 1C) and 2 were paint
Warmbloods with white faces and heterochromic iri-
des. The 2 remaining horses lacking BAER bilaterally
were 1 horse with chronic severe bilateral otitis and 1
American Miniature horse with facial deformation.
Bilateral partial hearing deficits were seen in 23 horses:
11 horses were diagnosed with multifocal brain disease
(Fig 1D, E), 10 with THO, 1 with vestibular disease
not associated with THO, and 1 with undetermined
etiology. The common causes of unilateral hearing loss
were THO (n = 10, Fig 1F), otitis media and interna
(n = 3), and multifocal brainstem disease (n = 2). See
Table 2.
For statistical purposes, only abnormal BAER
results from disease groups were used for comparison
with control horses. Statistical differences in both deri-
vations (V-M, V-C2) were found for latency of waves
I, III, and V between controls and horses with THO
but not between controls and horses with multifocal
brain disease (Table 3). Statistical differences were
found for amplitude ratios between horses with THO
and multifocal brain disease but not when each group
was compared with controls (Table 3). Because all 17
horses with SND were completely deaf and 10 of 11
Table 1. Signalment and clinical diagnosis by disease group.
Horses (N = 76) Breed Sex Age (Years) Signs
Clinical Diagnosis OutcomeGroup
Most
Common Female Gelding Stallion Mean (Range)
Most
Common
THO
(N = 20)
QH (10) 10 8 2 14 (9–19) Vestibular,
facial
paresis/
paralysis,
ulcerative
keratitis
Temporohyoid
osteoarthropathy
S (16)
EU (4)
SND
(N = 17)
American
Paint
Overo
(15)
9 6 2 4 (1–8) Behavior,
startle,
suspected
hearing
loss
Sensorineural deafness
associated to coat
color
S (17)
Brain
(N = 16)
NP 8 6 2 9 (1–27) Obtundation,
multiple
cranial
nerve
deficits,
tetraparesis,
proprioceptive
deficits
Infectious (+/- meningo)
encephalomyelitis (5),
intracranial masses (4),
Undetermined (4),
TBI (3)
S (4)
EU (12)
VD
(N = 11)
TB (8) 4 4 3 7 (1–28) Vestibular Undetermined (9),
TBI (1),
suspected EPM (1)
S (10)
U (1)
Otitis
(N = 4)
NP 2 1 1 11 (3–20) Headshaking,
head tilt
Otitis externa/media/
interna
S (1)
EU (3)
Others
(N = 8)
NP 2 3 3 5 (1–10) Variable Spinal cord disease (3),
altered behavior (3),
spontaneous otoacoustic
emissions (1), idiopathic
headshaking (1)
S (8)
Total
(N = 76)
NA 35 28 13 8.5 (1–28) Startle,
vestibular
NA S (55)
EU (19)
U (2)
THO, temporohyoid osteoarthropathy; SND, sensorineural deafness; brain, multifocal brain disease; VD, vestibular disease (not asso-
ciated with other BS deficits or THO); others, various disorders, TBI, traumatic brain injury; EPM, equine protozoal myeloencephalopa-
thy; NP, no predisposition; NA, not applicable; S, survivors; EU, euthanasia; U, unknown.
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horses with vestibular disease had BAER within
reference values, no comparisons of these groups with
control horses were made. Comparison of data from
control horses with that of the remaining groups was
not possible either because of small group size (horses
with otitis [n = 4] which had no detectable BAER in
the affected ear) or miscellaneous disorders not suit-
able for comparison.
Discussion
This study highlights the importance of performing
BAER examination as part of the diagnostic evalua-
tion in horses with suspected hearing loss manifested
by altered behavior (startling easily, lack of responsive-
ness to loud sounds, or difficulty training), otitis (head
shaking, head or ear rubbing, head tilt), cranial nerve
deficits as in horses with THO (mainly CN VII, VIII),
peripheral or central vestibular disease, and diffuse or
multifocal brain disease. Furthermore, examination of
hearing in horses with certain coat and eye color pat-
terns is warranted. Failure of embryonic melanocyte
migration from the neural crest to the stria vascularis
of the cochlea resulting in hair cell degeneration in the
organ of Corti has been associated with particular
phenotypes.23 The most common causes of BAER
abnormalities in this study were THO, congenital sen-
sorineural deafness, multifocal brain disease, and otitis.
The most common diagnosis associated with euthana-
sia in this study was multifocal brain disease. The
majority of horses with other disorders survived to
discharge.
Table 2. Findings by disease group based on BAER testing.
Horses (N = 76) Bilateral (N = 42)
Unilateral
(N = 15)
Normal (N = 19)Group Complete Partial C/p R L
THO (N = 20) 0 0 10 7 3 0
SND (N = 17) 17 0 0 0 0 0
Brain (N = 16) 0 9 2 1 1 3
VD (N = 11) 0 1 0 0 0 10
Otitis (N = 4) 1 0 0 2 1 0
Others (N = 8) 1 0 1 0 0 6
Total (N = 76) 19 10 13 10 5 19
Complete, bilateral loss of all BAER peaks; partial, bilateral partial hearing loss; C/P, bilateral hearing loss with total absence of
BAER peaks in 1 ear; R, right ear; L, left ear.
Table 3. BAER in healthy and diseased horses.
Horses
Latency (milliseconds) Amp (lV)
I III V I–III III–V I–V V/I
V-M 90 dB HL
Controls (N = 8) 2.21 (0.06)a 3.61 (0.17)a 5.36 (0.16)a 1.40 (0.15)a 1.74 (0.15)a 3.14 (0.12)a NA
THO (N = 20) 2.62 (0.59)b 4.01 (0.52)b 5.93 (0.54)b 1.39 (0.26)b 1.92 (0.11)a 3.31 (0.22)a NA
Brain (N = 16) 2.35 (0.19)a,b 3.79 (0.15)a,b 5.8 (0.59)a,b 1.5 (0.15)a 1.98 (0.63)a 3.48 (0.64)a NA
VD (N = 11) WNL except for
1 horse
SND (N = 17) No BAER No BAER No BAER No BAER No BAER No BAER No BAER
Otitis (N = 4) No BAER in
affected ear
Others (N = 8) Variable not shown
V-C2 90 dB HL
Controls (N = 8) 2.11 (0.06)a 3.62 (0.17)a 5.38 (0.12)a 1.45 (0.14)a 1.74 (0.17)a 3.22 (0.10)a 2.75 (1.46)a,b
THO (N = 20) 2.63 (0.68)b 4.01 (0.53)b 5.91 (0.51)b 1.38 (0.27)a 1.9 (0.11)a 3.28 (0.23)a 4.37 (2.42)a
Brain (N = 16) 2.24 (0.11)a,b 3.81 (0.17)a,b 5.65 (0.75)a,b 1.56 (0.13)a 1.98 (0.63)a 3.55 (0.59)a 1.60 (0.55)b
VD (N = 11) WNL except for
1 horse
SND (N = 17) No BAER No BAER No BAER No BAER No BAER No BAER No BAER
Otitis (N = 4) No BAER in
affected ear
Others (N = 8) Variable not shown
V-M, vertex to mastoid; V-C2, vertex to level of C2 vertebra; N, number of horses; WNL, within normal limits; No BAER, no identi-
fiable BAER (absent). Data are presented as mean (SD). Different superscripts between groups represent significant difference, and same
superscripts represent no statistical difference. Note, ear inserts add 0.9 milliseconds to latencies (I, III, V).
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Underestimation of the number of hearing abnormal-
ities within the hospital’s equine patient population
likely occurred with this study, given that only horses
that underwent BAER testing were included. Medical
records were screened using the words “deafness” and
“hearing loss”, and 4 additional horses were identified:
2 American Paint horses and 2 Quarter Horses with
multifocal brainstem disease but BAER had not been
performed. Subjective evaluation of hearing (response
to sound) as part of the neurologic examination was sel-
dom recorded in the medical records. This could have
resulted in failure to identify more horses with hearing
deficits. Furthermore, the fact that horses respond to
loud sound does not rule out hearing deficits, such as
partial loss or unilateral deficits, as described previously
in horses with THO.7 Appropriate localization of sound
requires intact bilateral hearing.24 To assess hearing
subjectively, it is important to determine if the animal is
capable not only of responding but also of orienting
toward the source of the sound. Clinicians’ approach
toward the examination of horses with neurologic dis-
ease also could have resulted in underestimation of
hearing loss. In this study, BAER testing occurred more
often when one of the authors (MA) was the primary
or consulting clinician on the case.
Because the most popular breeds seen at our institu-
tion include Quarter Horses, QH-related breeds, and
Thoroughbreds, an overall breed predisposition was
not observed in this study. However, when these
horses were grouped under disease categories, Ameri-
can Paint horses (15 of 15) were overrepresented in the
group of congenital sensorineural deafness (15 of 17
horses). These American Paint horses had splashed
white frame coat patterns with extensive head and
limb white markings, and blue or heterochromic irides.
These horses were tested and found to have the endo-
thelin B receptor (EDNBR) mutation associated with
overo lethal white foal syndrome.12,25,26 This gene
plays an essential role in neural crest development.23
Melanocytes are derived from the neural crest and
migrate to the skin and inner ear.23 Therefore, alter-
ation in the migration, differentiation, or function of
melanocytes results in pigment alterations and deaf-
ness.23 The remaining 2 horses were Warmblood
breeds with a paint coat color, white markings of the
face, and heterochromic irides. These horses were not
tested for the genetic mutation. A study performed at
our institution concluded that congenital sensorineural
deafness may exist in some but not all Paint horses
with particular coat color patterns such as splashed
white overo, frame overo, tovero, and overo-blend12
particularly those with extensive white markings on
the face and limbs and those with heterochromic or
completely blue eyes.12 Such horses should be tested
for the EDNBR mutation.12
Although a predisposition for sex or age group was
not observed, most horses were young adults at the
time of BAER testing (mean 8.5; median, 7-year old).
However, some of these horses had signs compatible
with hearing loss at an earlier age. Examples of these
included American Paint horses with congenital senso-
rineural deafness and horses with chronic THO. Con-
genital sensorineural deafness was identified in all
American Paint and suspected in paint Warmblood
horses. BAER in these horses was characterized by the
lack of identifiable peaks in either ear consistent with
complete loss of function. Horses diagnosed with THO
were older (mean, 14 years) than other groups. The
effects of aging on hearing in the horse have not been
fully evaluated.8,14 However, partial hearing loss was
reported in 4 horses, 17–22 years of age.14 Of 57
horses with hearing deficits, 14% (n = 8) were
>15 years of age. Of these 8 horses, 5 horses had
THO, 2 had chronic bilateral otitis, and 1 had vestibu-
lar disease of undetermined cause. Therefore, the
effects of aging on BAER could not be evaluated in
this study because of the presence of disease that could
result in deafness. Whether partial bilateral hearing
deficits in a 28-year-old horse with vestibular disease
were associated with the underlying cause of disease or
were the result of aging (presbycusis) could not be
determined.
The most common signs in horses with hearing loss
varied by disease and according to whether complete
or not or partial deafness was present. For example,
altered behavior and being startled easily was more
commonly reported in horses with complete bilateral
hearing loss independent of disease. Unilateral periph-
eral vestibular disease, facial nerve deficits, and corneal
ulceration were the most common signs in horses with
THO, as previously reported.7 Horses with multifocal
brain disease had signs consisting of altered state of
consciousness and multiple cranial nerve deficits. Hear-
ing deficits were more difficult to detect in horses with
altered state of consciousness (decreased or absent
response to various stimuli including sound). Head tilt,
shaking, and rubbing were the most common signs in
horses with otitis.
The most common causes of abnormal BAER find-
ings included THO (n = 20/20), congenital sensori-
neural deafness in horses with paint coat color
(American Paint horses [n = 15/17], Warmblood
[n = 2/17]), multifocal brain disease (n = 13/16), and
otitis media or interna (n = 4/4). Bilateral BAER def-
icits were more common in horses with congenital
sensorineural deafness (n = 17/17), THO (n = 10/20),
and multifocal brain disease (n = 11/16). BAER stud-
ies in horses with THO, congenital sensorineural
deafness of American Paint horses, and a single case
of glioblastoma multiforme have been described by
the authors.7,12,19 Causes of multifocal brain disease
with concurrent BAER abnormalities identified in
this study included melanoma, glioblastoma multi-
forme, intracranial abscess, suspected equine proto-
zoal myeloencephalitis, meningoencephalomyelitis
because of H. gingivalis and mixed bacterial growth
involving the inner ear, and traumatic brain injury.
The most common cause of unilateral BAER deficit
was THO (n = 10/20). Other causes of unilateral loss
included otitis media or interna (n = 3/4) and multi-
focal brain disease (n = 2/16). Horses with vestibular
disease and no other neurologic deficits had normal
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BAER findings. The exception was a single 28-year-
old horse in which the etiology remained undeter-
mined.
Other causes of hearing deficits included an Ameri-
can Miniature horse with congenital malformations
including facial deformation that had complete loss
of BAER bilaterally. This horse had no visible exter-
nal or internal acoustic meatus. Bone conduction test-
ing was not performed but, theoretically, the presence
of a response on this test would be consistent with a
severe conduction loss with sparing of the sensorineu-
ral pathway. A different horse had partial bilateral
hearing loss which the owner suspected to have devel-
oped acutely. The cause was unknown. A horse with
spontaneous otoacoustic emissions had a BAER
within reference range. Spontaneous otoacoustic emis-
sions are low intensity nonevoked emissions (sound
not triggered by external stimuli) generated at the
cochlea by the biomechanical activity of the outer
hair cells.27 Spontaneous otoacoustic emissions have
been reported in humans, dogs, cats, guinea pigs, and
a pony.17,27–29 Similar to our horse, the single
reported pony also had normal BAER, and the cause
of the spontaneous otoacoustic emissions was unde-
termined.17
Criteria for distinguishing normal versus abnormal
BAER included absence of BAER peaks, absence of
peaks following I or II, and abnormal prolongation of
interpeak intervals (I–III, III–V, and I–V).9 These cri-
teria serve to localize lesions in the cochlear nerve, cra-
nial brainstem, and caudal brainstem.9 Horses with
THO had prolonged latency of peaks I through V, but
the interpeak intervals were within reference range.
These findings supported a cochlear nerve abnormality
as shown in a previous study.7 Horses with multifocal
brain disease had peak latencies I through V within
reference range but prolonged interpeak intervals,
which supported a brainstem lesion. In further sup-
port, the peak V/I ratio in the vertex to C2 derivation
was lower (1.6) in these horses than in controls (2.75)
or in horses with a peripheral lesion (eg, THO, 4.37).
In dogs, low V/I peak ratio (≤0.5) in the vertex to mas-
toid derivation has been associated with a brainstem
lesion.2 Determination of BAER thresholds also is use-
ful to detect subtle hearing loss. Thresholds were not
analyzed in this study because they were not routinely
performed.
In conclusion, hearing deficits should be investi-
gated in horses with altered behavior (eg, being eas-
ily startled), THO, multifocal brainstem disease, and
otitis. Patients with intracranial masses, traumatic
brain injury, and infectious causes of brain disease
also may have alterations in auditory function.
Horses with certain coat patterns and eye color
should be screened for congenital sensorineural deaf-
ness. Facial deformities, the application of ototoxic
drugs, and the normal aging process may be associ-
ated with auditory dysfunction. Mild hearing deficits
such as those resulting from partial or complete
deafness in 1 ear may be easily missed on physical
examination. BAER testing is an objective, safe,
noninvasive, and easy to perform diagnostic modality
for the assessment of the auditory pathway in
horses.
Footnotes
a DANTEC electronics, Inc, Allendale, NJ
b TecaEP40/ST10, Teca Corp, Pleasantville, NY
c Nihon Kohden Neuropack, Neuro Medical Equipment, Inc,
Arlington, TX
d Viking IVD, Nicolet Biomedical Inc, Madison, WI
e VikingQuest, Nicolet Biomedical Inc
f TIP 300, Nicolet Biomedical, Inc
g FE-2, Grass/Astro-Med Inc, West Warwick, RI
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